Imunon (IMNN) Receivables - Accured (2011 - 2020)
Imunon's (IMNN) quarterly Receivables - Accured came in at $7866.0 in Q2 2020, down 88.02% YoY from $65673.0 in Q3 2019, and down 65.37% on a QoQ basis from $22713.0 in Q1 2020.
Imunon (IMNN) Receivables - Accured (2011 - 2020) Analysis & Trends
Imunon (IMNN) has 10 years of Receivables - Accured data on file, last reported at $7866.0 in Q2 2020.
- Quarterly Receivables - Accured fell 88.02% year-over-year to $7866.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $7866.0 (down 88.02% YoY) and the FY2019 annual result came in at $21369.0, down 68.72% from the prior year.
- Receivables - Accured fell to $7866.0 in Q2 2020, from $22713.0 in the prior quarter.
- In the past five years, Receivables - Accured ranged from a high of $78070.0 in Q1 2019 to a low of $21.0 in Q2 2016.
- A 5-year average of $39623.9 and a median of $40705.5 in 2017 frame the typical range for Receivables - Accured.
- Annual changes were most pronounced in 2016 — Receivables - Accured slumped 99.96% — and 2017, when it surged 1258.28%.
- Tracing IMNN's Receivables - Accured over 5 years: stood at $4008.0 in 2016, then surged by 1258.28% to $54440.0 in 2017, then advanced by 25.48% to $68309.0 in 2018, then sank by 68.72% to $21369.0 in 2019, then sank by 63.19% to $7866.0 in 2020.
- The last three Receivables - Accured figures came in at $7866.0 (Q2 2020), $22713.0 (Q1 2020), and $21369.0 (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Imunon | 8.53 Mn | 8.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 7,866.00 |
| Jun 30, 2020 | 7,866.00 |
| Mar 31, 2020 | 22,713.00 |
| Mar 31, 2020 | 22,713.00 |
| Dec 31, 2019 | 21,369.00 |
| Dec 31, 2019 | 21,369.00 |
| Sep 30, 2019 | 26,971.00 |
| Sep 30, 2019 | 26,971.00 |
| Jun 30, 2019 | 65,673.00 |
| Jun 30, 2019 | 65,673.00 |
| Mar 31, 2019 | 78,070.00 |
| Mar 31, 2019 | 78,070.00 |
| Dec 31, 2018 | 68,309.00 |
| Dec 31, 2018 | 68,309.00 |
| Sep 30, 2018 | 76,746.00 |
| Sep 30, 2018 | 76,746.00 |
| Jun 30, 2018 | 56,832.00 |
| Jun 30, 2018 | 56,832.00 |
| Mar 31, 2018 | 67,192.00 |
| Mar 31, 2018 | 67,192.00 |